Weekly type 2 diabetes jab could replace daily injections

Hundreds of thousands of people with type 2 diabetes in the UK may soon have access to a weekly insulin jab, a significant shift from daily injections. This new treatment, if approved, could reduce the number of annual injections by 86%, potentially transforming daily management for many.

The National Institute for Health and Care Excellence (Nice) has recommended the treatment, which reportedly works as effectively as daily jabs but requires only a once-weekly injection. Diabetes UK highlights the potential benefits for individuals with extra care needs who struggle with the demands of daily self-injection, suggesting it could improve their quality of life and help manage their condition more easily.

“

For some, especially those with additional care needs, moving from daily insulin injections to a once-weekly option could help manage their diabetes more easily, improving their quality of life.

This development is particularly promising for frailer individuals, those with sight loss, limited hand movement, or learning disabilities, who often require assistance with injections. The flexibility of a weekly dose could also benefit patients who find it difficult to adhere to a daily treatment regimen. Health officials are now awaiting a ruling from the Medicines and Healthcare products Regulatory Agency (MHRA) to determine if the treatment can be rolled out on the NHS.

Helen Knight, director of medicines evaluation at Nice, stated that the recommendation balances patient benefits with the efficient use of NHS funds. While Nice's guidance primarily applies to the NHS in England, other UK health bodies often follow its recommendations. The ultimate availability hinges on the MHRA's licensing decision.

“

This recommendation is the result of rigorous, evidence-based decision making, striking a balance between the benefits to patients and the best use of limited NHS funding.